Amsterdam-based Royal Philips has announced what company officials call its “ultimate ultrasound solution for breast assessment.” Available with the Philips EPIQ and Affiniti ultrasound systems, and the combination of the eL18-4 transducer and anatomical intelligence, this technology brings together high-quality imaging with clinical tools tailored for breast screenings.
With the new breast solution, clinicians can efficiently assess, monitor, and treat breast diseases, increasing diagnostic confidence and helping to improve patient care. The Philips ultimate ultrasound solution for breast assessment is CE marked and has received U.S. FDA 510(k) clearance. Developed in partnership with clinicians around the world, the Philips breast assessment solution reduces total exam time; eliminates the need for room or equipment changes; and avoids multiple appointments, which can result in additional anxiety for patients awaiting diagnosis.
Philips’ integrated breast solution combines four features that work together for screening and diagnosis. Specifically, PureWave eL18-4 ultra-broadband linear array transducer is a single transducer that delivers high-quality imaging for patients, including those who may be more technically challenging to image. Also, PureWave crystal technology delivers fine-elevation focusing to provide high detail resolution and tissue uniformity, as well as extended depth of field performance.
Moreover, anatomical intelligence for breast enhances reproducibility and streamlines workflow while preserving image quality during the breast exam. The automation and intelligence provides visual mapping and annotation of screened anatomy, with minimal user interaction, to give clinicians confidence while documenting full coverage of the breast during the acquisition phase.
Finally, ElastQ Imaging shear wave and strain elastography allows clinicians to rapidly assess various breast lesions. In combining both wave methods, ElastQ Imaging reveals more definitive information on tissue stiffness in the breast. Also, new precision biopsy allows physicians to enhance the patient experience by performing more targeted biopsies.